SYMPOSIUM 8 | DAY 2: 10.45 AM - 12.15 PM
A 10-Year Journey: the International Multi-site Trial of Schema Therapy, Including Group Schema Therapy for Borderline Personality Disorder Patients
by Joan Farrell, Arnoud Arntz, Ida Shaw, Gerhard Zarbock, Eva Fassbinder, and Florian Ruths
Chair: Joan Farrell
About the Presenters:
Joan Farrell, PhD, (with her partner Ida Shaw) has facilitated self-therapy groups for over 30 years leading to their book Experiencing Schema Therapy from the Inside Out: A Self-Practice/Self-Reflection Workbook for Therapists (Guilford Press, 2018).
She is an advanced level ISST Certified Trainer/Supervisor in individual & Group ST. She co-directs the Indianapolis Center of the Schema Therapy Institute Midwest, a training, research and practice center with ISST approved training programs in individual, Group and Child-Adolescent ST. She offers training nationally and in collaboration with ISST Training programs internationally – thirteen countries so far. She has published research articles, book chapters, a training DVD and three books on Schema Therapy. Group Schema Therapy for Borderline Personality Disorder, Wiley 2012 and The Schema Therapy Clinician’s Guide: A Complete Resource for Building and Delivering Individual, Group and Integrated Schema Mode Treatment Programs, Wiley, 2014.
Joan is a licensed Clinical Psychologist, Ph.D., an adjunct professor of clinical psychology, at Indiana University-Purdue University Indianapolis and was a faculty member of the Indiana University School of Medicine (IUSM), in Psychiatry for 25 years. She is the Research Director of the Center for BPD Treatment & Research of the IUSM/Eskenazi Community Mental Health Center. She is an investigator on a number of international schema therapy outcome studies and was awarded a National Institute of Mental Health (USA) award for a randomized controlled trial of Group Schema Therapy. Joan is a member of the Executive Board of the ISST and the Coordinator for Training & Certification 2012-2018.
Arnoud Arntz is professor of Clinical Psychology at the University of Amsterdam, the Netherlands, with an affiliation at Maastricht University, the Netherlands. His main research interests lie in the fields of PTSD and personality disorders, both applied and fundamental. He also practices as a psychotherapist at PsyQ in Amsterdam, where he treats patients with trauma and personality disorders. Together with Adam Radomsky he was editor of the Journal of Behavior Therapy and Experimental Psychiatry.
Ida Shaw, M.A. is the Training Director of the Center for Borderline Personality Disorder Treatment and Research, IUPUI. She is a member of the Training and Certification Advisory Board of ISST and Chair of the Child-Adolescent Certification Committee. Ida is the main clinical supervisor of the international BPD trial of group schema therapy, providing training and supervision for all trial therapists. She supervises the practice component of additional research projects on Avoidant personality disorder, dissociative disorders, complex trauma and child-adolescent treatment.
Eva Fassbinder works as assistant medical director at the Department of Psychiatry and Psychotherapy, Lübeck University. She is co-leader of the outpatient center at Lübeck University and her main efforts lie in the implementation and dissemination of outpatient psychotherapy programs. Main research interests: schema therapy and other third wave psychotherapies, group psychotherapy, personality disorders, posttraumatic stress disorders, depression, emotion regulation and online psychotherapy.
©2019 International Society of Schema Therapy e.V.
International Society of Schema Therapy e.V. is a not-for-profit organization. Glossop-Ring 35, DE-61118 Bad Vilbel, Germany
Why Schema Therapy?
Schema therapy has been extensively researched to effectively treat a wide variety of typically treatment resistant conditions, including Borderline Personality Disorder and Narcissistic Personality Disorder. Read our summary of the latest research comparing the dramatic results of schema therapy compared to other standard models of psychotherapy.